Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices 11677 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Comparison and Validation of 

Screening Tools for Substance Use 

Among Pregnant Women, DP15–003, 

initial review. 

SUMMARY: This document corrects a 

notice that was published in the Federal 

Register on February 18, 2015, Volume 

80, Number 32, pages 8661. The time 

and date should read as follows: 

Time and Date: 11:00 a.m.–6:00 p.m., 

March 18, 2015 (Closed). 

FOR FURTHER INFORMATION CONTACT: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway NE., 

Mailstop F46, Atlanta, Georgia 30341, 

Telephone: (770) 488–3585, EEO6@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–04467 Filed 3–3–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Epidemiologic Study of 

Interstitial Cystitis, DP15–010, initial 

review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 10:00 a.m.–6:30 p.m., 

March 26, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Epidemiologic Study of 

Interstitial Cystitis, DP15–010, initial 

review.’’ 

Contact Person for More Information: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway NE., 

Mailstop F–80, Atlanta, Georgia 30341, 

Telephone: (770) 488–3585, EEO6@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–04468 Filed 3–3–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), and pursuant to the 

requirements of 42 CFR 83.15(a), the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the 

aforementioned committee: 

Times and Dates: 

9:00 a.m.–4:30 p.m., Pacific Daylight 

Time, March 25, 2015 

9:00 a.m.–4:30 p.m., Pacific Daylight 

Time, March 26, 2015 

Public Comment Time and Date: 

4:30 p.m.–5:30 p.m.,* Pacific Daylight 

Time, March 25, 2015 

* Please note that the public comment 

period may end before the time 

indicated, following the last call for 

comments. Members of the public who 

wish to provide public comments 

should plan to attend the public 

comment session at the start time listed. 

Place: Red Lion Richland Hanford 

House, 802 George Washington Way, 

Richland, Washington 99352, Phone: 

509–946–7611; Fax: 509–943–8564. 

Audio Conference Call via FTS 

Conferencing. The USA toll-free, dial-in 

number is 1–866–659–0537 with a pass 

code of 9933701. 

Live Meeting Connection: https://

www.livemeeting.com/cc/cdc/join?id=

48H6RN&role=attend&pw=ABRWH&

i=i.ics; Meeting ID: 48H6RN; Entry 

Code: ABRWH. 

Status: Open to the public, limited 

only by the space available. The meeting 

space accommodates approximately 100 

people. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to the CDC. 

NIOSH implements this responsibility 

for CDC. The charter was issued on 

August 3, 2001, renewed at appropriate 

intervals, and will expire on August 3, 

2015. 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy facility 

who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters for Discussion: The agenda for 

the Advisory Board meeting includes: 

NIOSH Program Update; Department of 

Labor Program Update; Department of 

Energy Program Update; SEC Issues 

mstockstill on DSK4VPTVN1PROD with NOTICES

11678 Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices 

Work Group Report on ‘‘Sufficient 

Accuracy’’/Co-Worker Dose Modeling; 

SEC Petitions Update; SEC petitions for: 

Hanford (1984–1993; Richland, 

Washington); Dow Chemical 

Corporation (1947–1957; Pittsburgh, 

California), Grand Junction Operations 

Office (1975–2010; Grand Junction, 

Colorado), Idaho National Laboratory 

(1949–1970; Scoville, Idaho); an update 

on the SEC petition review for the 

Kansas City Plant (Kansas City, 

Missouri); Review of the DuPont 

Deepwater Works (Deepwater, New 

Jersey) Site Profile; and Board Work 

Sessions. 

The agenda is subject to change as 

priorities dictate. 

In the event an individual cannot 

attend, written comments may be 

submitted to the contact person below 

well in advance of the meeting. Any 

written comments received will be 

provided at the meeting in accordance 

with the redaction policy provided 

below. 

Policy on Redaction of Board Meeting 

Transcripts (Public Comment): (1) If a 

person making a comment gives his or 

her personal information, no attempt 

will be made to redact the name; 

however, NIOSH will redact other 

personally identifiable information, 

such as contact information, social 

security numbers, case numbers, etc., of 

the commenter. 

(2) If an individual in making a 

statement reveals personal information 

(e.g., medical or employment 

information) about themselves that 

information will not usually be 

redacted. The NIOSH Freedom of 

Information Act (FOIA) coordinator 

will, however, review such revelations 

in accordance with the Federal 

Advisory Committee Act and if deemed 

appropriate, will redact such 

information. 

(3) If a commenter reveals personal 

information concerning a living third 

party, that information will be reviewed 

by the NIOSH FOIA coordinator, and 

upon determination, if deemed 

appropriated, such information will be 

redacted, unless the disclosure is made 

by the third party’s authorized 

representative under the Energy 

Employees Occupational Illness 

Compensation Program Act (EEOICPA) 

program. 

(4) In general, information concerning 

a deceased third party may be disclosed; 

however, such information will be 

redacted if (a) the disclosure is made by 

an individual other than the survivor 

claimant, a parent, spouse, or child, or 

the authorized representative of the 

deceased third party; (b) if it is unclear 

whether the third party is living or 

deceased; or (c) the information is 

unrelated or irrelevant to the purpose of 

the disclosure. 

The Board will take reasonable steps 

to ensure that individuals making 

public comment are aware of the fact 

that their comments (including their 

name, if provided) will appear in a 

transcript of the meeting posted on a 

public Web site. Such reasonable steps 

include: (a) A statement read at the start 

of each public comment period stating 

that transcripts will be posted and 

names of speakers will not be redacted; 

(b) A printed copy of the statement 

mentioned in (a) above will be 

displayed on the table where 

individuals sign up to make public 

comments; (c) A statement such as 

outlined in (a) above will also appear 

with the agenda for a Board Meeting 

when it is posted on the NIOSH Web 

site; (d) A statement such as in (a) above 

will appear in the Federal Register 

Notice that announces Board and 

Subcommittee meetings. 

Contact Person for More Information: 

Theodore Katz, Designated Federal 

Officer, NIOSH, CDC, 1600 Clifton Road 

NE., MS E–20, Atlanta, Georgia 30333, 

telephone: (513) 533–6800, toll free: 1– 

800–CDC–INFO, email: dcas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

Notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–04465 Filed 3–3–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Low Income Home Energy 

Assistance Program (LIHEAP) Carryover 

and Re-allotment Report. 

OMB No.: 0970–0106. 

Description: The LIHEAP statute and 

regulations require LIHEAP grantees to 

report certain information to HHS 

concerning funds forwarded and funds 

subject to reallotment. The 1994 

reauthorization of the LIHEAP statute, 

the Human Service Amendments of 

1994 (Pub. L. 103–252), requires that the 

carryover and reallotment report for one 

fiscal year be submitted to HHS by the 

grantee before the Allotment for the next 

fiscal year may be awarded. 

We are requesting no changes in the 

collection of data with the Carryover 

and Reallotment Report For FY 20__, a 

form for the collection of data, and the 

Simplified Instructions for Timely 

Obligations of FY 20__ LIHEAP Funds 

and Reporting Funds For Carryover and 

Reallotment. The form clarifies the 

information being requested and 

ensures the submission of all the 

required information. The form 

facilitates our response to numerous 

queries each year concerning the 

amounts of obligated funds. Use of the 

form is voluntary. Grantees have the 

option to use another format. 

Respondents: State, Local or Tribal 

Government. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Carryover & Reallotment ................................................................................. 210 1 3 630 

Estimated Total Annual Burden Hours ..................................................... ........................ ........................ ........................ 630 

In compliance with the requirements 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

mstockstill on DSK4VPTVN1PROD with NOTICES